Related Experiment Video
Updated: May 18, 2026

07:48
Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
Published on: April 25, 2018
Docetaxel-induced photo-recall phenomenon
Catherine Droitcourt1, Hélêne Le Hô, Henri Adamski
1Department of Dermatology, Pontchaillou Hospital, Rennes, France. catherine.droitcourt@gmail.com
Photodermatology, Photoimmunology & Photomedicine
|September 29, 2012
Summary
The photo-recall phenomenon is a rare skin reaction to drugs, appearing on sun-exposed skin after UV exposure. This case highlights docetaxel-induced photo-recall, emphasizing its recognition to prevent misdiagnosis and unnecessary treatment changes.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- The photo-recall phenomenon is a rare, specific skin reaction.
- It manifests as a phototoxic eruption on previously sun-damaged skin after systemic drug administration.
- While commonly associated with methotrexate, it's infrequently reported with other antineoplastic agents.
Observation:
- A case of docetaxel-induced photo-recall skin rash is presented.
- The patient was undergoing treatment for non-small-cell lung cancer.
- The rash appeared on areas with prior ultraviolet-induced solar erythema.
Findings:
- Docetaxel can induce the photo-recall phenomenon, a rare dermatologic reaction.
- This reaction occurs in areas previously affected by sunburn.
- The condition is distinct from drug allergy and radiation recall.
Implications:
- Recognizing docetaxel-induced photo-recall is crucial for oncologists.
- Prompt identification can prevent misdiagnosis as a drug allergy.
- Appropriate management includes photoprotection and corticosteroids, allowing continued chemotherapy.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

